GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | 8/14/2026 4:50:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $127,623,697 | EPS -$11.77 | ||
| Apimeds Pharmaceuticals US, Inc. (APUS) | 5/26/2026 4:12:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $141,219,157 | EPS -$2.26 | ||
| Apimeds Pharmaceuticals US, Inc. (APUS) | 5/4/2026 7:04:25 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $164,183,736 | EPS -$0.55 | ||
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2/27/2026 6:12:03 AM | View | Proxy | SEC | |||||||
| Apimeds Pharmaceuticals US, Inc. (APUS) | 11/12/2025 4:54:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | ||||
| Apimeds Pharmaceuticals US, Inc. (APUS) | 8/19/2025 4:21:51 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | ||||
| Apimeds Pharmaceuticals US, Inc. (APUS) | 5/20/2025 6:13:24 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | ||||
| Apimeds Pharmaceuticals US, Inc. (APUS) | 5/2/2025 6:13:30 AM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | ||||
| Apimeds Pharmaceuticals US, Inc. (APUS) | 4/15/2025 5:36:01 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 |